<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01672138</url>
  </required_header>
  <id_info>
    <org_study_id>TANTRA_TCAI</org_study_id>
    <nct_id>NCT01672138</nct_id>
  </id_info>
  <brief_title>Pulmonary Vein Antrum Isolation (PVAI) Plus Isolation of Complex Fractionated Atrial Electrograms (CAFE) and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation</brief_title>
  <acronym>TANTRA</acronym>
  <official_title>PVAI Plus Isolation of CAFEs and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Cardiac Arrhythmia Research Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>California Pacific Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas Cardiac Arrhythmia Research Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to examine the long-term success rate of catheter ablation in non-paroxysmal
      atrial fibrillation patients using different ablation strategies such as 1) PVAI alone, 2)
      PVAI+ CFAE, 3) PVAI+ CFAE+ non-PV trigger ablation.

      [ PVAI: Pulmonary Vein Antrum Isolation CFAE: Complex Fractionated Atrial Electrograms Non-PV
      triggers: Triggers arising from sites other than pulmonary veins]
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Back ground: Pulmonary vein antrum isolation (PVAI) as a lone procedure, is known to have
      limited success rate in terms of long-term recurrence-free survival in non-paroxysmal atrial
      fibrillation (NPAF) and additional ablations isolating extra-PV triggers seem to improve the
      outcome (1). The extra-PV triggers include complex fractionated atrial electrograms (CFAEs)
      and triggers from other sites such as left atrial posterior wall, superior vena cava, left
      atrial appendage, ligament of Marshall and coronary sinus (1, 2). These are known to be
      independent predictors of late AF recurrence following catheter ablation (3, 4, and 5). In a
      meta-analysis of several studies comparing long-term efficacy of different ablation
      strategies, Li et al have reported superior success rate of combined CFAE ablation and
      standard PVAI in maintaining long-term sinus-rhythm (6). Similarly, earlier studies have
      demonstrated better ablation outcome in NPAF when non-PV triggers sites were isolated along
      with PVAI (5, 7). However, limited data is available showing a comparison of the lasting
      efficacy of the above three procedures when used in different combinations.

      Hypothesis: The combined ablation strategy including PVAI, ablation of CFAE and extra-PV
      triggers has the highest likelihood of maintaining long-term sinus rhythm in patients with
      NPAF.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of atrial arrhythmia</measure>
    <time_frame>3 years</time_frame>
    <description>Any episode of AF/AT (atrial tachycardia) longer than 30 seconds will be considered as recurrence). Episodes that occur during the first 3 months of the procedure (blanking period) will not be considered as recurrence.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvement in quality of life</measure>
    <time_frame>3 years</time_frame>
    <description>Improvement in quality of life</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">186</enrollment>
  <condition>Persistent Atrial Fibrillation</condition>
  <condition>Long-standing Persistent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Pulmonary Vein Antrum Isolation alone</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study I</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PVAI+ CFAE ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study II</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>PVAI + CFAE + non-PV triggers ablation</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pulmonary Vein Antrum Isolation</intervention_name>
    <description>Radio-frequency catheter ablation of pulmonary vein antrum</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Study I</arm_group_label>
    <arm_group_label>Study II</arm_group_label>
    <other_name>PVAI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>CFAE ablation</intervention_name>
    <description>Catheter ablation of CFAEs</description>
    <arm_group_label>Study I</arm_group_label>
    <arm_group_label>Study II</arm_group_label>
    <other_name>CFAE</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Isolation of non-PV triggers</intervention_name>
    <description>Catheter ablation of triggers originating from extra-PV sites</description>
    <arm_group_label>Study II</arm_group_label>
    <other_name>Non-PV triggers ablation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age â‰¥ 18 years

          2. Patients presenting with drug-refractory long-standing persistent AF (LSPAF)

          3. Ability to understand and provide signed informed consent

        Exclusion Criteria:

          1. Previous catheter ablation or MAZE procedure in left atrium

          2. Reversible causes of atrial arrhythmia such as hyperthyroidism, sarcoidosis, pulmonary
             embolism etc
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrea Natale, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>TCAI</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>St. david's medical Center</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac arrhythmia Institute, St. David's Hospital</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2012</study_first_submitted>
  <study_first_submitted_qc>August 21, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2012</study_first_posted>
  <last_update_submitted>April 25, 2017</last_update_submitted>
  <last_update_submitted_qc>April 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Cardiac Arrhythmia Research Foundation</investigator_affiliation>
    <investigator_full_name>Andrea Natale</investigator_full_name>
    <investigator_title>Executive medical director, TCAI</investigator_title>
  </responsible_party>
  <keyword>PVAI</keyword>
  <keyword>CFAE</keyword>
  <keyword>NPAF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

